Coronavirus Pneumonia: Clinical Trials

3 trials for Coronavirus Pneumonia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow Coronavirus Pneumonia: new trials by email Literature Review of Coronavirus Pneumonia trials Research Report on Coronavirus Pneumonia

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Timings for Awake Prone Positioning in Covid-19 Patients
Coronavirus Pneumonia
CompletedRuijin Hospital4752023-04-012023-11-30
A Study of CX2101A Enteric-Coated Tablets in Healthy Chinese Adult Subjects
Remdesivir, CX2101A, Placebo - COVID-19, Coronavirus Pneumonia
Phase 1CompletedHeronova Pharmaceuticals632022-12-262025-03-06
Follow-up of Covid-19 Long Term Sequelae
Not applicable (observational study) - COVID-19 Pneumonia, COVID-19 Respiratory Infection
CompletedAzienda Ospedaliera Universitaria Integrata Verona75992021-04-162024-10-28

Narrower conditions

COVID-19 (2)  ·  Coronavirus Infections (1)  ·  Disease (1)  ·  Severe Acute Respiratory Syndrome (1)

Broader conditions

Coronaviridae Infections (2)  ·  Infections (2)  ·  Lung Diseases (2)  ·  Nidovirales Infections (2)  ·  Pneumonia (2)  ·  Pneumonia, Viral (2)  ·  RNA Virus Infections (2)  ·  Respiratory Tract Diseases (2)  ·  Respiratory Tract Infections (2)  ·  Virus Diseases (2)  ·  Coronavirus Infections (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Observation (1)  ·  remdesivir (1)

Sponsors

Azienda Ospedaliera Universitaria Integrata Verona (1)  ·  Heronova Pharmaceuticals (1)  ·  Ruijin Hospital (1)

Countries

China (2)  ·  Belgium (1)  ·  France (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Republic of the Congo (1)  ·  Spain (1)

Top investigators

Evelina Tacconelli, Professor (1)

Results publications

PMID 37654668, PMID 38368846